title: Should we test for genotype in deciding on age-related eye disease study supplementation?
authors.affiliation: Washington, DC.
authors.forename: Janet
authors.initials: J
authors.lastname: Wittes
authors.affiliation: Ann Arbor, Michigan.
authors.forename: David C
authors.initials: DC
authors.lastname: Musch
mesh_terms: D000368:Aged; D000975:Antioxidants / Q000008:administration & dosage; D017242:Complement Factor H / Q000235:genetics; D019587:Dietary Supplements; D005260:Female; D005820:Genetic Testing; D005838:Genotype; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D011506:Proteins / Q000235:genetics; D017967:Zinc Compounds / Q000008:administration & dosage
chemical_list: C514392:ARMS2 protein, human; D000975:Antioxidants; C493495:CFH protein, human; D011506:Proteins; D017967:Zinc Compounds; D017242:Complement Factor H